Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 30 June 2021

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 63 Renminbi (CNY) 16 Euro (EUR) 8 Other currencies (CAD, DKK, GBP, HDK, SEK) 6 Indian rupee (INR) 5 Swiss franc (CHF) 2 #03375e #f2a58f #cfa400 #b84b18 #B7D4D8 #6c7332 #94743a #423E3D #3880C0 #AD2D3C
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 62 Private companies 21 Cash and cash equivalents 8 Funds 8 Other assets 1 #03375e #f2a58f #cfa400 #b84b18 #B7D4D8 #6c7332 #94743a #423E3D #3880C0 #AD2D3C
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Profitable 29 Phase III 12 Phase II 17 Phase I 11 Preclinical 6 Products on the market 25 #03375e #f2a58f #cfa400 #b84b18 #B7D4D8 #6c7332 #94743a #423E3D #3880C0 #AD2D3C
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 33 Oncology 28 Central nervous system 14 Immunology/Inflammation 6 Orphan diseases 6 Digital Health 5 Medical technology / diagnostics 4 Kidney and metabolic diseases 2 Infectious diseases 2 #03375e #f2a58f #cfa400 #b84b18 #B7D4D8 #6c7332 #94743a #423E3D #3880C0 #AD2D3C